Validation of the Asthma Severity Scoring System (ASSESS) in the ALLIANCE Cohort.

Child Adult Adolescent Humans Aged Middle Aged Reproducibility of Results Surveys and Questionnaires Asthma / diagnosis
ALLIANCE adult asthma asthma asthma control asthma severity children pediatric asthma validation study

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
06 2023
Historique:
received: 27 09 2022
revised: 02 01 2023
accepted: 06 01 2023
medline: 9 6 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

The Asthma Severity Scoring System (ASSESS) quantifies asthma severity in adolescents and adults. Scale performance in children younger than 12 years is unknown. To validate the ASSESS score in the All Age Asthma Cohort and explore its use in children younger than 12 years. Scale properties, responsiveness, and known-group validity were assessed in 247 children (median age, 11 years; interquartile range, 8-13 years) and 206 adults (median age, 52 years; interquartile range, 43-63 years). Overall, measures of internal test consistency and test-retest reliability were similar to the original data of the Severe Asthma Research Program. Cronbach α was 0.59 in children aged 12 to 18 years and 0.73 in adults, reflecting the inclusion of multiple and not-always congruent dimensions to the ASSESS score, especially in children. Analysis of known-group validity confirmed the discriminatory power, because the ASSESS score was significantly worse in patients with poor asthma control, exacerbations, and increased salbutamol use. In children aged 6 to 11 years, test-retest reliability was inferior compared with that in adults and adolescents (Cronbach α, 0.27) mostly because of a less lung function impairment in children with asthma of this age group. Known-group validity, however, confirmed good discriminative power regarding severity-associated variables similar to adolescents and adults. Test-retest reliability and validity of the ASSESS score was confirmed in the All Age Asthma Cohort. In children aged 6 to 11 years, internal consistency was inferior compared with that in older patients with asthma; however, test validity was good and thus encourages age-spanning usage of the ASSESS score in all patients 6 years or older.

Sections du résumé

BACKGROUND
The Asthma Severity Scoring System (ASSESS) quantifies asthma severity in adolescents and adults. Scale performance in children younger than 12 years is unknown.
OBJECTIVE
To validate the ASSESS score in the All Age Asthma Cohort and explore its use in children younger than 12 years.
METHODS
Scale properties, responsiveness, and known-group validity were assessed in 247 children (median age, 11 years; interquartile range, 8-13 years) and 206 adults (median age, 52 years; interquartile range, 43-63 years).
RESULTS
Overall, measures of internal test consistency and test-retest reliability were similar to the original data of the Severe Asthma Research Program. Cronbach α was 0.59 in children aged 12 to 18 years and 0.73 in adults, reflecting the inclusion of multiple and not-always congruent dimensions to the ASSESS score, especially in children. Analysis of known-group validity confirmed the discriminatory power, because the ASSESS score was significantly worse in patients with poor asthma control, exacerbations, and increased salbutamol use. In children aged 6 to 11 years, test-retest reliability was inferior compared with that in adults and adolescents (Cronbach α, 0.27) mostly because of a less lung function impairment in children with asthma of this age group. Known-group validity, however, confirmed good discriminative power regarding severity-associated variables similar to adolescents and adults.
CONCLUSIONS
Test-retest reliability and validity of the ASSESS score was confirmed in the All Age Asthma Cohort. In children aged 6 to 11 years, internal consistency was inferior compared with that in older patients with asthma; however, test validity was good and thus encourages age-spanning usage of the ASSESS score in all patients 6 years or older.

Identifiants

DOI: 10.1016/j.jaci.2023.01.027 PMID: 36804993
pubmed: 36804993
pii: S0091-6749(23)00207-5
doi: 10.1016/j.jaci.2023.01.027
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1525-1535.e4

Investigateurs

Oliver Fuchs (O)
Barbara Roesler (B)
Nils Welchering (N)
Naschla Kohistani-Greif (N)
Johanna Kurz (J)
Katja Landgraf-Rauf (K)
Kristina Laubhahn (K)
Nicole Maison (N)
Claudia Liebl (C)
Bianca Schaub (B)
Markus Ege (M)
Erika von Mutius (E)
Sabina Illi (S)
Alexander Hose (A)
Esther Zeitlmann (E)
Mira Berbig (M)
Carola Marzi (C)
Christina Schauberger (C)
Ulrich Zissler (U)
Carsten Schmidt-Weber (C)
Isabell Ricklefs (I)
Gesa Diekmann (G)
Lena Liboschik (L)
Gesche Voigt (G)
Laila Sultansei (L)
Markus Weckmann (M)
Matthias V Kopp (MV)
Gyde Nissen (G)
Inke R König (IR)
Dominik Thiele (D)
Thomas Bahmer (T)
Anne-Marie Kirsten (AM)
Frauke Pedersen (F)
Henrik Watz (H)
Benjamin Waschki (B)
Klaus F Rabe (KF)
Christian Herzmann (C)
Mustafa Abdo (M)
Heike Biller (H)
Karoline I Gaede (KI)
Xenia Bovermann (X)
Alena Steinmetz (A)
Berrit Liselotte Husstedt (BL)
Catharina Nitsche (C)
Vera Veith (V)
Marlen Szewczyk (M)
Folke Brinkmann (F)
Anna-Maria Dittrich (AM)
Christine Happle (C)
Ruth Grychtol (R)
Aydin Malik (A)
Nicolaus Schwerk (N)
Christian Dopfer (C)
Mareike Price (M)
Gesine Hansen (G)
Adan Chari Jirmo (AC)
Anika Habener (A)
None Dipl-Biol
David S DeLuca (DS)
Svenja Gaedcke (S)
Bin Liu (B)
Mifflin-Rae Calveron (MR)
Stefanie Weber (S)
Svenja Foth (S)
Chrysanthi Skevaki (C)
Harald Renz (H)
Meike Meyer (M)
Tom Schildberg (T)
Ernst Rietschel (E)
Silke van Koningsbruggen-Rietschel (S)
Miguel Alcazar (M)

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Ruth Grychtol (R)

Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Lennart Riemann (L)

Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Else Kröner-Fresenius Stiftung, Forschungskolleg TITUS, Hannover Medical School, Hannover, Germany; Institute of Immunology, Hannover Medical School, Hannover, Germany.

Svenja Gaedcke (S)

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Bin Liu (B)

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

David DeLuca (D)

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Reinhold Förster (R)

Institute of Immunology, Hannover Medical School, Hannover, Germany; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2155 "RESIST", Germany.

Nicole Maison (N)

Institute for Asthma and Allergy Prevention (IAP), Helmholtz Zentrum Munich, German Research Center for Environmental Health (GmbH), Munich, Germany; Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany; Comprehensive Pneumology Center-Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.

Dominik Thiele (D)

Institute of Medical Biometry and Statistics, University Medical Center Schleswig-Holstein, Luebeck, Germany; Airway Research Center North (ARCN), Member of German Center for Lung Research (DZL), Germany.

Nikolas Jakobs (N)

Airway Research Center North (ARCN), Member of German Center for Lung Research (DZL), Germany; Section for Pediatric Pneumology and Allergology, University Medical Center Schleswig-Holstein, Luebeck, Germany.

Thomas Bahmer (T)

Airway Research Center North (ARCN), Member of German Center for Lung Research (DZL), Germany; Department of Internal Medicine I, Pneumology, University Hospital Schleswig-Holstein, Kiel, Germany; LungenClinic Grosshansdorf, Grosshansdorf, Germany.

Meike Meyer (M)

Faculty of Medicine, University Children's Hospital, University of Cologne, Cologne, Germany.

Svenja Foth (S)

Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany; University Children's Hospital Marburg, University of Marburg, Marburg, Germany.

Stefanie Weber (S)

Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany; University Children's Hospital Marburg, University of Marburg, Marburg, Germany.

Ernst Rietschel (E)

Faculty of Medicine, University Children's Hospital, University of Cologne, Cologne, Germany.

Klaus F Rabe (KF)

Airway Research Center North (ARCN), Member of German Center for Lung Research (DZL), Germany; LungenClinic Grosshansdorf, Grosshansdorf, Germany.

Matthias V Kopp (MV)

Airway Research Center North (ARCN), Member of German Center for Lung Research (DZL), Germany; Section for Pediatric Pneumology and Allergology, University Medical Center Schleswig-Holstein, Luebeck, Germany; Department of Pediatric Respiratory Medicine, Inselspital, University Children's Hospital of Bern, University of Bern, Bern, Switzerland.

Erika von Mutius (E)

Institute for Asthma and Allergy Prevention (IAP), Helmholtz Zentrum Munich, German Research Center for Environmental Health (GmbH), Munich, Germany; Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany; Comprehensive Pneumology Center-Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.

Anna-Maria Dittrich (AM)

Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Gesine Hansen (G)

Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany; Else Kröner-Fresenius Stiftung, Forschungskolleg TITUS, Hannover Medical School, Hannover, Germany; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2155 "RESIST", Germany. Electronic address: hansen.gesine@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Validation of the Asthma Severity Scoring...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Validation of the Asthma Severity Scoring...